| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|
| Revenue | $2.3B | $2.3B | $2.0B | $1.5B |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| R&D Expense | — | — | — | — |
| SG&A Expense | $0.6B | $0.4B | $0.4B | $0.3B |
| Operating Income | $-0.1B | $-0.7B | $0.2B | $0.2B |
| Net Income | $-0.3B | $-0.7B | $0.0B | $0.0B |
| EPS (Basic) | $-1.79 | $-4.50 | $0.26 | $0.06 |
| EPS (Diluted) | $-1.82 | $-4.53 | $0.25 | $0.06 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|
| Total Assets | $5.3B | $5.9B | $6.5B | $5.9B |
| Current Assets | $0.7B | $0.8B | $0.6B | $0.8B |
| Cash & Equivalents | $0.2B | $0.2B | $0.2B | $0.5B |
| Total Liabilities | $4.7B | $5.0B | $4.8B | $4.2B |
| Current Liabilities | $0.4B | $0.4B | $0.5B | $0.5B |
| Stockholders' Equity | $0.6B | $0.9B | $1.7B | $1.6B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.2B | $0.2B | $0.3B |
| Investing Cash Flow | $0.1B | $-0.5B | $-0.8B | $-0.8B |
| Capital Expenditures | — | — | — | — |
| Financing Cash Flow | $-0.3B | $0.2B | $0.3B | $0.9B |